Natasha O. Moraka

发表

Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable

Sikhulile Moyo, Melanie Prague, Max Essex, 2016, Journal of Clinical Microbiology.

B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine

B. Chi, J. Lindsey, R. Bosch, 2018, Front. Immunol..

HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.

S. Lockman, S. Gaseitsiwe, A. Weinberg, 2019, The Journal of infectious diseases.

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana

D. Kuritzkes, M. Lichterfeld, Zixin Hu, 2021, AIDS.

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana

S. Lockman, S. W. Mpoloka, E. Bile, 2022, Journal of global antimicrobial resistance.

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana

J. Jarvis, T. Harrison, S. Gaseitsiwe, 2020, Viruses.

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation

F. Noubary, S. Gaseitsiwe, S. Moyo, 2023, Infectious Agents and Cancer.

HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads

S. Gaseitsiwe, M. Essex, V. Novitsky, 2022, Infection and drug resistance.

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana

Iain J. MacLeod, S. Gaseitsiwe, I. Kasvosve, 2017, BMC Infectious Diseases.

Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana

J. Jarvis, T. Harrison, S. Gaseitsiwe, 2020, Medicine.

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana

S. Gaseitsiwe, S. Moyo, W. Choga, 2023, Vaccines.

Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana

S. Lockman, S. Gaseitsiwe, S. Moyo, 2023, Research square.

Child HIV Exposure and CMV Seroprevalence in Botswana: No Associations With 24-Month Growth and Neurodevelopment

Paige L. Williams, S. Lockman, S. Gaseitsiwe, 2019, Open forum infectious diseases.

Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes

Prisca K. Thami, S. Lockman, S. Gaseitsiwe, 2019, Journal of acquired immune deficiency syndromes.

High prevalence of pre-treatment and acquired HIV-1 drug resistance mutations among non-citizens living with HIV in Botswana

S. Gaseitsiwe, S. Moyo, T. Marukutira, 2024, Frontiers in microbiology.

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana

S. Lockman, S. Gaseitsiwe, S. Moyo, 2023, Scientific reports.

Fostemsavir resistance-associated polymorphisms in HIV-1 subtype C in a large cohort of treatment-naïve and treatment-experienced individuals in Botswana

S. Lockman, S. Gaseitsiwe, V. Novitsky, 2023, Microbiology spectrum.